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Cytoskeletal reorganization and migration are critical responses which enable vascular
smooth muscle cells (VSMCs) cells to evade, compensate, or adapt to alterations in
biomechanical stress. An increase in wall stress or biomechanical stretch as it is elicited
by arterial hypertension promotes their reorganization in the vessel wall which may lead
to arterial stiffening and contractile dysfunction. This adaptive remodeling process is
dependent on and driven by subtle phenotype changes including those controlling the
cytoskeletal architecture and motility of VSMCs. Recently, it has been reported that
the transcription factor nuclear factor of activated T-cells 5 (TonEBP/NFAT5) controls
critical aspects of the VSMC phenotype and is activated by biomechanical stretch. We
therefore hypothesized that NFAT5 controls the expression of gene products orchestrating
cytoskeletal reorganization in stretch-stimulated VSMCs. Automated immunofluorescence
and Western blot analyses revealed that biomechanical stretch enhances the expression
and nuclear translocation of NFAT5 in VSMCs. Subsequent in silico analyses suggested
that this transcription factor binds to the promotor region of ACTBL2 encoding kappa-
actin which was shown to be abundantly expressed in VSMCs upon exposure to
biomechanical stretch. Furthermore, ACTBL2 expression was inhibited in these cells upon
siRNA-mediated knockdown of NFAT5. Kappa-actin appeared to be aligned with stress
fibers under static culture conditions, dispersed in lamellipodia and supported VSMC
migration as its knockdown diminishes lateral migration of these cells. In summary, our
findings delineated biomechanical stretch as a determinant of NFAT5 expression and
nuclear translocation controlling the expression of the cytoskeletal protein ACTBL2. This
response may orchestrate the migratory activity of VSMCs and thus promote maladaptive
rearrangement of the arterial vessel wall during hypertension.
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INTRODUCTION
The defined arrangement of vascular smooth muscle cells
(VSMCs) and extracellular matrix in the media of the arterial wall
provides the structural basis for the physiological properties of
the arterial system. On the one hand, this flexible architectural
concept allows for the development of elastic but less contrac-
tile conduit arteries or less elastic but highly contractile resistance
arteries. On the other hand, pathophysiological alterations in the
circulatory systemmay be compensated by adaptingmatrix struc-
ture and cellular arrangement in the arterial wall. Even a subtle
but chronic increase in arterial pressure as it may occur during
essential or idiopathic hypertension is known to cause a slowly
progressive structural rearrangement of the arterial media leading
to arterial stiffening and contractile dysfunction. Besides pro-
liferation, repositioning and therefore migration of VSMCs is a
prerequisite for this process.
During hypertension-induced arterial remodeling, a chronic
increase in wall stress or biomechanical stretch is likely to act
as the most important determinant promoting activation and
migration of VSMCs within the media of the artery (Olivetti
et al., 1982; Feldner et al., 2011; Pfisterer et al., 2012). Directed
migration requires a polarized reorganization of the actin
cytoskeleton to define the cell’s front with a loose actin scaf-
fold and the cell’s rear with stabilized (stress) fibers. Depending
on the local balance of stabilizing and destabilizing mechanisms,
globular actin (G-actin) rapidly polymerizes to form filamentous
actin (F-actin) or depolymerizes to liberate G-actin monomers.
From the six mammalian actin genes, the regulation of cytoskele-
tal actins ACTB (β-actin) and ACTG2 (γ-actin) has been studied
in some detail whereby the latter encodes for the largest actin iso-
form and its expression is regulated by CArG promotor elements
as a target of the transcriptional coactivator myocardin (Sun et al.,
2009). Moreover, the expression of the VSMC-specific α-smooth
muscle actin (αSMA) appears to be controlled by both myocardin
(Li et al., 2003) and the hypertonicity-responsive transcription
factor nuclear factor of activated T-cells 5 (NFAT5) (Halterman
et al., 2011).
NFAT5 is known to be involved in controlling the expression
of genes involved in cellular homeostasis (Miyakawa et al., 1999),
migration and proliferation of cells (Jauliac et al., 2002; Go et al.,
2004; O’connor et al., 2007). In VSMCs, its expression and activity
is regulated by platelet derived growth factor BB (PDGF-BB)—a
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humoral factor that drives mitogenic responses and chemotac-
tic migration. In a recent study, we revealed that biomechani-
cal stretch of VSMCs promotes expression and translocation of
NFAT5 into the nucleus. As a consequence, NFAT5 up-regulates
the expression of tenascin-C—a protein of the extracellular
matrix that orchestrates the migration of VSMCs (Scherer et al.,
2014). However, impaired migration of NFAT5-deficient cells was
only partially rescued by exogenous TNC indicating that this
transcription factor may control the expression of other genes
rate-limiting for this cellular activity. While the general impact
of NFAT5 on cellular migration has repeatedly been reported
(O’connor et al., 2007; Halterman et al., 2012a), the molecular
basis of corresponding context-specific functions of NFAT5 in
individual cell types was not much elucidated so far. Against this
background, our study investigated the impact of NFAT5 on the
expression of novel cytoskeletal proteins which may contribute to
the migratory capacity of VSMCs.
MATERIALS AND METHODS
CELL CULTURE
Human arterial smooth muscle cells (HUASMCs) were freshly
isolated from individual umbilical cords and grown on collagen
I-bonded BioFlex® plates (Flexcell International, Hillsborough,
NC, USA) with DMEM medium containing 15% FCS (osmolar-
ity: 305 mosm ± 4.08 mOsm). The isolation of HUASMCs was
approved by the local Ethics Committee (Heidelberg, Germany;
reference 336/2005) and conformed to the principles outlined in
the Declaration of Helsinki (1997). Stretch was typically applied
at a frequency of 0.5Hz and an elongation of 0–13% for 24 h
by using a Flexercell FX-5000 tension system. In addition, cells
were exposed to the following reagent: 40μmol/L Etomoxir
(Calbiochem, Germany). The compoundwas dissolved in DMSO.
Pure DMSO (0.4%, v/v) was simultaneously applied to the con-
trol cells as solvent control.
IMMUNOCYTOCHEMISTRY
Cells were fixed in ice-cold methanol for 15min and allowed
to dry for 20min. Rehydrated cells were blocked with 0.25%
casein and 0.1% BSA for 30min. Cells were incubated with
rabbit anti-NFAT5 antibody 1:100 (sc-13035, Santa Cruz, CA)
or anti-ACTBL2 antibody 1:100 (abcam Cambridge, UK) at
4◦C overnight. After washing, cells were incubated with don-
key anti-rabbit-Cy3 1:100 (Dianova, Hamburg, Germany) for
1 h and mounted with Mowiol (Calbiochem, Hilden, Germany).
Nuclei were visualized by counterstaining the cells with DAPI
(Invitrogen). Fluorescence intensity was recorded using a fluores-
cence microscope and quantitated utilizing either the Olympus
Xcellence software or the TissueQuest Analysis software.
TRANSFECTION WITH siRNA
HUASMCs were transfected with short interfering RNA directed
against NFAT5 (5 ′-CCA GTT CCT ACA ATG ATA A-3 ′). As
control commercially available siGENOME non-targeting siRNA
(Thermo Scientific, Bonn, Germany) was applied. For each well
of a 6-well plate, 3μg of siRNA was diluted in Opti-MEM
I (Invitrogen) together with 3μl of MATra-si reagent (IBA,
Göttingen, Germany) to give a final volume of 200μl. After
mixing and incubating for 20min at ambient temperature, the
solution was added onto the cells which had been cultured in 2ml
Opti-MEM I prior to the transfection. Cells were then incubated
on a magnet plate (IBA) at 37◦C and 5% CO2. After 15min cells
were washed and cultured in normal cell medium for a resting
period of 48 h for NFAT5 knockdown.
ANALYSIS OF GENE EXPRESSION
Total RNA was isolated from the cultured HUASMCs using the
peqGOLD Total RNA Kit (Peqlab) according to the manufac-
turer’s instructions. Subsequently, reverse transcription (RT) and
quantitative polymerase chain reaction (qPCR) for ACTBL2 and
60S ribosomal protein L32 (RPL32) cDNA as an internal standard
was performed. ACTBL2 primers were bought from Qiagen and
primers for RPL32 were used for amplification based on the fol-
lowing sequence: for 5 ′-GTT CAT CCG GCA CCA GTC AG-3 ′,
rev 5 ′-ACG TGC ACA TGA GCT GCC TAC-3 ′
WESTERN BLOT
HUASMCs were lysed using sample buffer containing 1% Triton
X-100 and 0.1μmol/L DTT or buffers for preparing nuclear
and cytosolic fractions. Protein samples were separated by
SDS (10%), blotted onto nitrocellulose membranes and ana-
lyzed by chemiluminescence-based immunodetection according
to standard procedures. Primary antibodies: rabbit anti-NFAT5
1:500 (Santa Cruz Biotechnology), rabbit anti-ACTBL2 (κ-actin)
1:1000 (abcam), mouse anti-β-actin 1:10,000 (abcam), rabbit
anti-histone H3 1:1000 (abcam), rabbit anti-alpha-Tubulin (Cell
Signaling) 1:1000.
NUCLEAR EXTRACTION
Nuclear protein extraction was performed according to the fol-
lowing protocol: HUASMCs were lysed using buffer I containing
10mM HEPES, 10mM KCl, 1μM EDTA, 1μM EGTA, 15%
Nonidet, protease and phosphatase inhibitors. After centrifuga-
tion (12,000 × g at 4◦C for 15min) the supernatant (cytosolic
fraction) was transferred to a new tube and stored or immedi-
ately used for Western blotting. The remaining pellet containing
the nuclear fraction was dissolved in 40μl buffer II consisting of
20mMHEPES, 400mMNaCl, 0.01M EDTA, 0.01M EGTA, 15%
Nonidet and protease and phosphatase inhibitors. Subsequently,
this solution was sonicated two times for 5 s at 50 Watts at 4◦C.
After centrifugation (12,000× g at 4◦C for 15min) the super-
natant containing the nuclear fraction was transferred to a new
tube and stored at −80◦C or was immediately used.
BIOINFORMATIC ANALYSIS
About 3203 bp of the promoter sequence upstream of the human
ACTBL2 translation start site (Homo sapiens ACTBL2, accession
NG_029637, position 28727 to 32239) were analyzed using the
MatInspector software (Genomatrix Software, Munich Germany)
for potential NFAT5 consensus sequences.
CELL MIGRATION ASSAY
Cultured HUASMCs were seeded into 24-well culture plates with
4mm thick and 10mm long silicon walls in the center of each
well, after transfection with specific siRNA, control siRNA or left
untreated. After 24 h the silicon walls were removed and after
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48 h, the distance between the cell borders was measured at 2×
magnification or cells were fixed and stained for κ-actin.
STATISTICAL ANALYSIS
All results are expressed as means ± SD of n individual experi-
ments. Differences between individual experimental groups were
analyzed by unpaired Student’s t-test or non-parametric Mann–
Whitney U-test, with p < 0.05 considered statistically significant.
RESULTS
BIOMECHANICAL DEFORMATION OF VSMCs PROMOTES NUCLEAR
TRANSLOCATION OF NFAT5
A general response of VSMC on a biomechanical stimulation is
an adaptive rearrangement of the cytoskeleton. This may either
allow the cells to generate contractile forces acting against the
stimulus or to evade them through local repositioning or migra-
tion, respectively. Corresponding changes in gene expression have
to support any of these options and are controlled by concerted
transcriptional activity. In this context, it has been shown that the
transcription factor NFAT5 controls gene expression mediating
activity and migration of VSMCs (Halterman et al., 2011) and is
activated by biomechanical stimuli (Scherer et al., 2014). To verify
that the transcription factor NFAT5 enters the nucleus under cor-
responding conditions, nuclear and cytoplasmic protein extracts
were analyzed and revealed an increased level of NFAT5 in the
nuclei of stretch-stimulated VSMCs (Figure 1A). Likewise, auto-
mated tissue-FACS-based immunofluorescence analyses indi-
cated an elevated NFAT5-specific fluorescence intensity in the
nuclei and cytoplasm in biomechanically stimulated VSMCs
(Figure 1B). To exclude any impact of the osmolarity of the
culture medium on NFAT5 activity under the chosen experimen-
tal conditions, this parameter was determined upon exposing
VSMCs to biomechanical stretch for 24 h but did not show any
relevant changes (control: 305 ± 4.08 mOsm; stretch: 297 ± 2.89
mOsm, n = 4).
NFAT5 CONTROLS EXPRESSION AND PROTEIN ABUNDANCE OF
κ-ACTIN IN STRETCH-EXPOSED VSMCs
By performing in silico analyses, we showed that the promo-
tor sequence of the human ACTBL2 gene—enconding κ-actin,
a novel member of the actin family that was originally detected
in hepatoma cells (Chang et al., 2006)—contains several putative
NFAT5 binding sites (Figure 2A). Consequently, knockdown of
NFAT5 by siRNA induced a significant reduction in expression
of the ACTBL2 gene (Figure 2B) and decreased the abundance
of NFAT5 as well as κ-actin in the nuclei or cyotoplasm of
stretch-stimulated VSMCs (Figure 2C).
EXPRESSION OF ACTBL2 IN STRETCH-EXPOSED VSMCs IS
DEPENDENT ON PALMITOYLATION OF NFAT5
According to the aforementioned findings, the abundance of
κ-actin was significantly increased in biomechanically stimu-
lated VSMCs (Figures 3A,B). As earlier results suggested that
NFAT5 activity is regulated by stretch-dependent palmitoyla-
tion (Eisenhaber et al., 2011; Scherer et al., 2014) we assumed
that the class of carnitine palmitoyl transferases is crucial for
the palmitoylation process and thus NFAT5 activity and κ-
actin expression. We scrutinized this hypothesis by investigating
FIGURE 1 | Biomechanical stretch induces nuclear translocation of
Nuclear factor of activated T cells 5 (NFAT5). HUASMCs were exposed
to biomechanical stretch for 24 h. Subsequent Western blot analyses of
nuclear and cytosolic protein fractions showed an increase of nuclear
NFAT5 abundance compared to control conditions (A). Automated
immunofluorescence analyses (TissueGnostics/TissueQuest) revealed a
significant increase of NFAT5 positive nuclei (B, ∗∗∗p < 0.001 vs. control,
n = 3) and NFAT5-specific nuclear/cytoplasmic fluorescence intensity (B,
∗∗∗p < 0.001 vs. control, n = 3) in stretch-stimulated VSMCs which is also
demonstrated by corresponding scattergramms. The threshold was set
according to the basal NFAT5 fluorescence intensity under control
conditions (scale bar: 100μm).
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FIGURE 2 | ACTBL2 is a transcriptional target of NFAT5. In silico promoter
analysis of the human ACTBL2 promoter revealed six putative NFAT5 binding
sites (A). The first 3203 bp of the promoter sequence upstream of the
transcription start site were analyzed. The maximum core similarity (Core
sim.) of 1.0 is only reached when the highest conserved bases of a matrix are
exactly matched by the sequence (cf. capitals in the sequence). A good
match to the matrix has a similarity of >0.80 (Matrix sim.). Quantitative PCR
(qPCR) of stretch-stimulated HUASMCs treated with NFAT5-specific siRNA
(siNFAT5) showed a significant decrease in ACTBL2 mRNA expression
compared to stretch-stimulated control siRNA(siScramble)-transfected cells
(B, ∗∗p < 0.01 vs. control siRNA, n = 3 scale bar: 20μm). SiRNA-mediated
knockdown of NFAT5 (C, ∗p < 0.05 vs. siScramble) decreased κ-actin (C,
∗p < 0.05 vs. siScramble) in stretch-stimulated VSMCs as evidenced by
immunofluorescence analyses (scale bar: 100μm).
stretch-induced nuclear translocation of NFAT5 in VSMCs which
were treated with etomoxir—an inhibitor of the mitochondrial
carnitine palmitoyltransferase 1 that is tested in clinical trials
for its capacity to treat congestive heart failure (Holubarsch
et al., 2007). While this drug inhibited NFAT5 from entering the
nucleus (Figure 3C), it also attenuated the gene expression of the
ACTBL2 (Figure 3D) and protein expression (Figure 3E).
κ-ACTIN IS INVOLVED IN STRESS FIBER ORGANIZATION AND
MIGRATION OF VSMCs
Orchestrated and continuous architectural adaptation of the
cytoskeleton is a prerequisite for repositioning or migration of
cells and defines a typical response to an altered biomechanical
load. Structurally, the β-actins constitute the most relevant and
abundant proteins of the cytoskeleton and are thus rate-limiting
for its adequate function. However, the function of κ-actin in this
context has not been explored so far. High resolution contrast
enhancing immunofluorescence analyses showed that this pro-
tein is located along stress fibers in resting VSMCs (Figure 4A).
Alike β-actin, dispersed κ-actin accumulates at the border of the
lamellipodia, is basically absent from the migration front and
implemented in stress fibers in the cell’s rear (Figures 4B,C).
As silencing of ACTBL2 gene expression (Figure 4D) had no
effect on spreading or morphology of resting cells (Figure 4E),
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FIGURE 3 | ACTBL2 expression in stretch-stimulated SMCs is
dependent on the Carnitine palmitoyltransferase family 1 (CPT1).
Immunofluorescence analyses indicated a significant increase of
κ-actin abundance in HUASMCs upon stretch stimulation (A,
∗∗∗p < 0.001 vs. control, n = 3; scale bar: 20μm) which was
confirmed by Western blot analyses (B, ∗∗∗p < 0.001 vs.
control, n = 3). Etomoxir, a specific CPT1-inhibitor (40μM) reduced the
(Continued)
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FIGURE 3 | Continued
stretch-induced NFAT5 translocation which was determined by analyzing
nuclear protein extracts (C, ∗∗∗p < 0.001 control DMSO vs. stretch DMSO,
∗p < 0.05 stretch DMSO vs. stretch Etomoxir, n = 5). Quantitative real-time
PCR revealed a decline in ACTBL2 mRNA expression in stretch-stimulated
Etomoxir-treated HUASMCs (D, ∗p < 0.05 vs. stretch DMSO, n = 3).
Stretch-dependent (24 h) increase in κ-actin protein abundance is attenuated
upon treatment with Etomoxir as evidenced by immunofluorescence
detection (E, ∗∗∗p < 0.001 vs. static DMSO, ##p < 0.01 vs. stretch DMSO;
bar graphs represent the mean (±SD) fluorescence intensity of κ-actin in ten
microscopic fields of view; representative images are shown on the right,
scale bar: 100μm).
FIGURE 4 | κ-actin modulated VSMC migration. κ-actin is localized in
stress fibers of resting cells (A) and dispersed in protrusions of
migrating cells (B,C) as evidenced by contrast enhancing
immunofluorescence detection. ACTBL2 knockdown efficiency was
verified by RT-PCR and immunofluorescence analysis 2 days after
transfection (D, ∗∗p < 0.01 and ∗∗∗p < 0.001 vs. siScramble, n = 3) and
did not affect spreading or viability of the HUASMCs (E, scale bar:
100μm). In contrast to control, planar cell migration is inhibited in
HUASMCs after ACTBL2 silencing (F,G, ∗∗∗p < 0.001 vs. siScramble,
n = 6, scale bar: 50μm).
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we next analyzed its impact on the dynamic rearrangement of
the cytoskeleton as it usually occurs during cellular migration.
By utilizing a lateral sheet migration assay, we revealed that
knockdown of κ-actin impairs VSMCs migration (Figures 4F,G).
Furthermore, detailed time-lapse analyses of these cells indicated
that silencing of ACTBL2 expression partially impairs directional
migration (Supplementary Videos 1, 2) and thus led to a 3- to
4-fold increase in basically immobile cells.
DISCUSSION
NFAT5 was originally identified as a hypertonicity-responsive
transcription factor that regulates cellular homeostasis
(Miyakawa et al., 1999). By triggering phosphorylation of
the carboxy-terminal transactivation domain of NFAT5, osmotic
stress promotes its nuclear translocation and transcriptional
activity (Lopez-Rodriguez et al., 1999; Miyakawa et al., 1999;
Dahl et al., 2001; Ferraris et al., 2002; Lee et al., 2003).
Meanwhile, NFAT5 has also been reported to control gene
expression in angiotensin II- or PDGF-BB-stimulated VSMCs
(Halterman et al., 2011). Thereby, it contributes to a pheno-
typic switch of these cells which includes the transition from
a quiescent and resting to an activated and motile phenotype
that is usually associated with vascular remodeling processes.
An important determinant mediating such a phenotype change
and realignment of VSMCs in the arterial media is a chronic
increase in wall stress or biomechanical stretch. Elevation of
these forces occurs during hypertension (Olivetti et al., 1982;
Haudenschild et al., 1985) which is accompanied by thickening,
stiffening and malfunction of the arterial vessel wall (Olivetti
et al., 1982; Intengan and Schiffrin, 2000). Changes in cellular
activity preceding these structural alterations are controlled
by a wide range of transcription factors such as AP-1 and SRF
(Wang et al., 2004; Demicheva et al., 2008). In this context, we
revealed that stretch-stimulated VSMCs respond by enhancing
protein abundance and nuclear translocation of NFAT5 (Scherer
et al., 2014) which is in line with observations made in this
study. Although several kinases have been reported to control
NFAT5 activity (Jauliac et al., 2002; Halterman et al., 2012b),
p38 MAP kinase and ERK1/2-dependent signaling appear to
affect neither expression nor translocation of NFAT5 under
these conditions. However, its palmitoylation appears to be
crucial for the stretch-induced nuclear translocation—a covalent
attachment of fatty acids to cysteine, sometimes serine and
threonine residues of the protein core. Such a modification has
been reported to regulate the entry of NFAT5 into the nucleus in
response to osmotic stress (Eisenhaber et al., 2011). Additionally,
our study suggests that the activity of type 1 carnitine palmi-
toyl transferases (CPT1) is rate-limiting for the translocation
process occurring in VSMCs upon exposure to biomechanical
stretch.
Impaired nuclear translocation as well as knockdown of
NFAT5 attenuated the expression of its transcriptional target
genes such as tenascin-C which has been identified in earlier
studies. With ACTBL2–a gene encoding κ-actin–we revealed a
novel NFAT5 target whose product constitutes one component
of the VSMC cytoskeleton. κ-actin is a 42 kDa actin isoform that
was originally detected in hepatoma cells (Chang et al., 2006)
and showed single nucleotide polymorphisms in its promotor
that were associated with orthostatic hypotension and supine-
standing blood pressure changes (Hong et al., 2013). At first
glance, κ-actin behaves like β-actin as it is organized in stress
fibers and follows a distribution in migrating cells as has been
repeatedly described for β-actin (Gerthoffer, 2007). For directed
migration, cellular lamellipodia are extended by actin polymer-
ization and nucleation of new filaments which is governed by
a plethora of actin-binding proteins such as the actin-related
protein 2/3 (ARP2/3) complex. However, phylogenetic analyses
indicated that the ACTBL2 sequences were genetically distant
from those encoding α-, β-, and γ-actin (Chang et al., 2011).
Thus, κ-actin may interact with an individual set of proteins.
For instance, interaction of κ-actin and prefoldin 2 but not 1—
members of a heterohexameric chaperone protein family that
is capable to capture unfolded actin (Vainberg et al., 1998)—
appear to be diminished as compared to β-actin (Chang et al.,
2006). On the functional level, increasing the protein abundance
of κ-actin in stretch-stimulated VSMCs must have an advantage
for the cells as may be deduced from their impaired migra-
tory capacity upon silencing ACTBL2 gene expression. In fact,
increased levels of κ-actin expression are preserved in the course
of hepatocarcinogenesis and grants hepatoma cells a growth
advantage. Likewise, abundant κ-actin levels are associated with a
poorer postoperative disease-free survival of hepatocellular car-
cinoma patients (Chang et al., 2011) which may also be based
on an enhanced migratory capacity of these cells. Therefore,
it is tempting to speculate that etomoxir may diminish metas-
tasis of distinct tumors by indirectly inhibiting expression of
κ-actin and the activity of the pro-migratory transcription factor
NFAT5.
Collectively, our findings suggest that (i) biomechanical
stretch promotes the CPT1-dependent nuclear translocation of
NFAT5 into the nucleus of cultured human arterial smooth
muscle cells and (ii) this transcription factor controls the
expression of κ-actin that contributes to VSMC migration.
In the context of hypertension these cascade of events may
support VSMCs in acquiring an activated phenotype. The
stretch-induced translocation of NFAT5 therefore constitutes
a novel regulatory mechanism underlying this phenomenon
during stretch or wall stress-induced maladaptive remodeling
processes which occur in the early phases of hypertension or
atherosclerosis.
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